Cargando…
The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy
Leprosy is a chronic infectious disease caused by Mycobacterium leprae. According to official reports from 121 countries across five WHO regions, there were 213 899 newly diagnosed cases in 2014. Although leprosy affects the skin and peripheral nerves, it can present across a spectrum of clinical an...
Autores principales: | Fonseca, Adriana Barbosa de Lima, Simon, Marise do Vale, Cazzaniga, Rodrigo Anselmo, de Moura, Tatiana Rodrigues, de Almeida, Roque Pacheco, Duthie, Malcolm S., Reed, Steven G., de Jesus, Amelia Ribeiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292790/ https://www.ncbi.nlm.nih.gov/pubmed/28162092 http://dx.doi.org/10.1186/s40249-016-0229-3 |
Ejemplares similares
-
Mycobacterium leprae Recombinant Antigen Induces High Expression of Multifunction T Lymphocytes and Is Promising as a Specific Vaccine for Leprosy
por: Bezerra-Santos, Márcio, et al.
Publicado: (2018) -
sTREM-1 and TNF-α levels are associated with the clinical outcome of leprosy patients
por: Bezerra-Santos, Márcio, et al.
Publicado: (2023) -
sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis
por: Silva, Ricardo Luís Louzada, et al.
Publicado: (2017) -
Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy
por: Mieras, Liesbeth, et al.
Publicado: (2016) -
The simulation design in health and nursing: A scoping review
por: Oliveira Silva, George, et al.
Publicado: (2022)